McLean EMG Electrodiagnostic vs OnADose

"Try before you buy" - Download the FREE App, which includes sample content. An in-App purchase is required to unlock all content. This step-by-step approach to performing and interpreting EMG and nerve conduction studies will prepare trainees, fellows, and attendings to meet the challenges encountered in daily practice with confidence. Revised, updated, and expanded second edition of the premier learning guide for residents, McLean EMG Guide emphasizes skills and concepts required for success in mastering basic electrodiagnostic techniques. This step-by-step approach to performing and interpreting EMG and nerve conduction studies will prepare trainees, fellows, and attendings to meet the challenges encountered in daily practice with confidence. McLean EMG Guide is broken into short formatted chapters covering instrumentation, basic nerve conduction and needle EMG techniques, interpretation, applications for common clinical problems, and a new chapter on ultrasound. The procedures are laid out as illustrated tables with specifics for lead placement, stimulation, sample waveforms, and photographs to guide electrodiagnostic set-ups. Clinical presentation, anatomy, recommended studies, normal values, pearls and tips, and key findings are presented throughout in bulleted text for a thorough, more focused guidebook. Multiple choice questions and answers with rationales reinforce learning for those wishing to review concepts through self-guided assessment. Key Features * Updates to all chapters with new figures and diagrams and more multiple-choice questions with answers * Brand new chapter on the use of ultrasound with electrodiagnosis * Checklists with key steps and takeaways for each study * Clear, easy-to-understand tables and photos illustrate each set-up and study * Codifies what you need to know to make a diagnosis in the EMG laboratory No internet connection is required to access the content after the initial download. Find information quickly using powerful SmartSearch technology. Search part of term for those hard to spell medical terms. Content licensed from printed ISBN 10: 0826172121 Content licensed from printed ISBN 13: 9780826172129 SUBSCRIPTION : Please choose an auto renewable subscription plan to receive content access & continuous updates. Your subscription automatically renews as per your plan, so you always have the latest content. Yearly auto-renewing payments-$69.99 6 months auto-renewing payments -$39.99 Payment will be charged to your iTunes Account at confirmation of purchase. Subscription automatically renews unless auto-renew is turned off at least 24-hours before the end of the current period. Subscription may be managed by the user & auto-renewal can be disabled at any time by going to your device “Settings” and tapping “iTunes & App Store”. Any unused portion of a free trial period will be forfeited when you purchase a subscription, where applicable. If you have any questions or comments, email us any time: customersupport@skyscape.com or call 508-299-30000 Privacy Policy-https://www.skyscape.com/terms-of-service/privacypolicy.aspx Terms and Conditions-https://www.skyscape.com/terms-of-service/licenseagreement.aspx Editor(s): Samuel Chu MD, Prakash Jayabalan MD, PhD, Christopher J. Visco MD Publisher: Springer Publishing Company

OnADose is an onabotulinumtoxinA dosing and reconstitution educational tool for spasticity, cervical dystonia, and chronic migraine. This app is intended for training use by US healthcare professionals ONLY. Patients should seek a doctor’s advice before making any medical decisions. OnabotulinumtoxinA Important Safety Information OnabotulinumtoxinA Indications Chronic Migraine -OnabotulinumtoxinA is indicated for the prophylaxis of headaches in adult patients with Chronic Migraine (≥ 15 days per month with headache lasting 4 hours a day or longer). Limitations of Use -Safety and effectiveness have not been established for the prophylaxis of episodic migraine (14 headache days or fewer per month) in 7 placebo-controlled studies. Spasticity -OnabotulinumtoxinA is indicated for the treatment of spasticity in patients 2 years of age and older. Limitations of Use -OnabotulinumtoxinA has not been shown to improve upper extremity functional abilities or range of motion at a joint affected by a fixed contracture. Cervical Dystonia -OnabotulinumtoxinA is indicated for the treatment of adults with Cervical Dystonia to reduce the severity of abnormal head position and neck pain associated with Cervical Dystonia. IMPORTANT SAFETY INFORMATION, INCLUDING BOXED WARNING WARNING: DISTANT SPREAD OF TOXIN EFFECT Postmarketing reports indicate that the effects of onabotulinumtoxinA and all botulinum toxin products may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These may include asthenia, generalized muscle weakness, diplopia, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence and breathing difficulties. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. The risk of symptoms is probably greatest in children treated for spasticity but symptoms can also occur in adults treated for spasticity and other conditions, particularly in those patients who have an underlying condition that would predispose them to these symptoms. In unapproved uses and in approved indications, cases of spread of effect have been reported at doses comparable to those used to treat cervical dystonia and spasticity and at lower doses. Contraindications -Hypersensitivity to any botulinum toxin preparation or to any of the components in the formulation -Infection at the proposed injection site Warnings and Precautions -Spread of toxin effects; swallowing and breathing difficulties can lead to death. Seek immediate medical attention if respiratory, speech or swallowing difficulties occur -Potency Units of onabotulinumtoxinA are not interchangeable with other preparations of botulinum toxin products -Potential serious adverse reactions after onabotulinumtoxinA injections for unapproved uses -Concomitant neuromuscular disorder may exacerbate clinical effects of treatment -Use with caution in patients with compromised respiratory function -Bronchitis and upper respiratory tract infections in patients treated for spasticity Adverse Reactions The most common adverse reactions (≥5% and >placebo, if applicable) are: -Chronic Migraine: neck pain, headache -Adult Spasticity: pain in extremity -Pediatric Spasticity: upper respiratory tract infection -Cervical Dystonia: dysphagia, upper respiratory infection, neck pain, headache, increased cough, flu syndrome, back pain, rhinitis Drug Interactions -Patients receiving concomitant treatment of onabotulinumtoxinA and aminoglycosides or other agents interfering with neuromuscular transmission (e.g., curare-like agents), or muscle relaxants, should be observed closely because the effect of onabotulinumtoxinA may be potentiated Use in Specific Populations -Pregnancy: Based on animal data, may cause fetal harm Please see full Prescribing Information for onabotulinumtoxinA. Available at http://www.rxabbvie.com. Copyright ©2022 AbbVie. All rights reserved.